98% , 83150-76-9
Synonym(s):
Octreotide acetate salt
CAS NO.：83150-76-9
Empirical Formula: C49H66N10O10S2
Molecular Weight: 1019.24
MDL number: MFCD07780622
EINECS: 1533716-785-6
| Pack Size | Price | Stock | Quantity |
| 10mg | RMB768.00 | In Stock |
|
| 20mg | RMB1094.40 | In Stock |
|
| 100mg | RMB1425.60 | In Stock |
|
| 1g | RMB7869.60 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Melting point: | >140°C (dec.) |
| Boiling point: | 1447.2±65.0 °C(Predicted) |
| Density | 1.39±0.1 g/cm3(Predicted) |
| storage temp. | -20°C |
| solubility | Soluble in acetic acid, DMSO, and methanol |
| form | Solid |
| pka | 12.60±0.70(Predicted) |
| color | White to Off-White |
| Water Solubility | Soluble to 1.20 mg/ml in water |
| Stability: | Hygroscopic |
| InChIKey | DEQANNDTNATYII-MEUDYGGUSA-N |
Description and Uses
Octreotide is a long-acting somatostatin analog indicated for symptomatic control in acromegaly and gastroenteropancreatic tumors. Other potential uses under investigation include diabetes, psoriasis and Alzheimer's disease.
Octreotide Acetate is the acetate salt of a synthetic long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. It inhibits the secretion of growth hormone, glucagon, insulin, gastrin, vasoactive intestinal peptide, secretin, motilin and pancreatic polypeptide. Octreotide acetate was uses for the treatment of severe diarrhea and flushing associated with malignant carcinoid tumors, acromegaly, and diarrhea associated with VIPoma; and, then in 2010, for the treatment of neuroendocrine tumors.
Safety
| WGK Germany | 3 |
